Tanja Blagus

986 total citations
31 papers, 380 citations indexed

About

Tanja Blagus is a scholar working on Molecular Biology, Biotechnology and Cancer Research. According to data from OpenAlex, Tanja Blagus has authored 31 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Biotechnology and 5 papers in Cancer Research. Recurrent topics in Tanja Blagus's work include Microbial Inactivation Methods (7 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Tanja Blagus is often cited by papers focused on Microbial Inactivation Methods (7 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Tanja Blagus collaborates with scholars based in Slovenia, Belgium and Greece. Tanja Blagus's co-authors include Maja Čemažar, Gregor Serša, Boštjan Markelc, Špela Kos, Damijan Miklavčič, Simona Kranjc, Tanja Dolinšek, Uroš Cvelbar, Lara Prosen and Maša Bošnjak and has published in prestigious journals such as PLoS ONE, Radiology and International Journal of Molecular Sciences.

In The Last Decade

Tanja Blagus

26 papers receiving 372 citations

Peers

Tanja Blagus
Zewen Wei China
Richard J. Connolly United States
Marius Müller Switzerland
Yolmari Cruz United States
Kenneth N. Aycock United States
Feroz Jameel United States
Zewen Wei China
Tanja Blagus
Citations per year, relative to Tanja Blagus Tanja Blagus (= 1×) peers Zewen Wei

Countries citing papers authored by Tanja Blagus

Since Specialization
Citations

This map shows the geographic impact of Tanja Blagus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Blagus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Blagus more than expected).

Fields of papers citing papers by Tanja Blagus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Blagus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Blagus. The network helps show where Tanja Blagus may publish in the future.

Co-authorship network of co-authors of Tanja Blagus

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Blagus. A scholar is included among the top collaborators of Tanja Blagus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Blagus. Tanja Blagus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blagus, Tanja, et al.. (2025). Case Report: I want more olanzapine: pharmacogenetic insights into a patient's preference for high-dose olanzapine. Frontiers in Psychiatry. 16. 1633198–1633198.
2.
Mlinšek, Gregor, et al.. (2025). Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment of Slovenian patients undergoing kidney transplantation in the U-PGx PREPARE study. The Pharmacogenomics Journal. 25(1-2). 6–6. 1 indexed citations
4.
Blagus, Tanja, et al.. (2024). Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics. Frontiers in Psychiatry. 15. 1363051–1363051. 2 indexed citations
5.
Blagus, Tanja, et al.. (2024). Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study. Frontiers in Pharmacology. 15. 1418567–1418567. 2 indexed citations
6.
Kos, Špela, Tanja Jesenko, & Tanja Blagus. (2024). In Vivo Wound Healing Model for Characterization of Gene Electrotransfer Effects in Mouse Skin. Methods in molecular biology. 2773. 87–96. 2 indexed citations
7.
Koritnik, Blaž, et al.. (2024). Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy. Cellular and Molecular Neurobiology. 44(1). 71–71. 1 indexed citations
9.
Blagus, Tanja, Maja Trošt, Milica G. Kramberger, et al.. (2024). Genetic variability of incretin receptors affects the occurrence of neurodegenerative diseases and their characteristics. Heliyon. 10(20). e39157–e39157. 1 indexed citations
10.
Blagus, Tanja, et al.. (2023). Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode. Frontiers in Psychiatry. 14. 1250253–1250253. 1 indexed citations
11.
Blagus, Tanja, et al.. (2022). Genetic Variability of the Vitamin D Receptor Affects Susceptibility to Parkinson’s Disease and Dopaminergic Treatment Adverse Events. Frontiers in Aging Neuroscience. 14. 853277–853277. 6 indexed citations
12.
Bizjan, Barbara Jenko, Georgios Leventopoulos, Tanja Blagus, et al.. (2020). Multiomics Analysis Coupled with Text Mining Identify Novel Biomarker Candidates for Recurrent Cardiovascular Events. OMICS A Journal of Integrative Biology. 24(4). 205–215. 3 indexed citations
13.
Kos, Špela, Tanja Blagus, Maja Čemažar, et al.. (2017). Safety aspects of atmospheric pressure helium plasma jet operation on skin: In vivo study on mouse skin. PLoS ONE. 12(4). e0174966–e0174966. 61 indexed citations
14.
Kos, Špela, Tanja Blagus, Maja Čemažar, et al.. (2016). Electrotransfer parameters as a tool for controlled and targeted gene expression in skin. Molecular Therapy — Nucleic Acids. 5(8). e356–e356. 25 indexed citations
15.
Dolinšek, Tanja, Boštjan Markelc, Maša Bošnjak, et al.. (2015). Endoglin Silencing has Significant Antitumor Effect on Murine Mammary Adenocarcinoma Mediated by Vascular Targeted Effect. Current Gene Therapy. 15(3). 228–244. 20 indexed citations
16.
Bošnjak, Maša, Tanja Dolinšek, Maja Čemažar, et al.. (2015). Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma. Gene Therapy. 22(7). 578–590. 23 indexed citations
17.
Blagus, Tanja, Maja Čemažar, Gregor Serša, et al.. (2014). A cell-based biosensor system HepG2CDKN1A–DsRed for rapid and simple detection of genotoxic agents. Biosensors and Bioelectronics. 61. 102–111. 13 indexed citations
18.
Blagus, Tanja, Boštjan Markelc, Maja Čemažar, et al.. (2013). In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery. Journal of Controlled Release. 172(3). 862–871. 55 indexed citations
19.
Bošnjak, Maša, Lara Prosen, Tanja Dolinšek, et al.. (2013). Biological Properties of Melanoma and Endothelial Cells after Plasmid AMEP Gene Electrotransfer Depend on Integrin Quantity on Cells. The Journal of Membrane Biology. 246(11). 803–819. 14 indexed citations
20.
Dolinšek, Tanja, Boštjan Markelc, Lara Prosen, et al.. (2012). Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiology and Oncology. 46(4). 302–311. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026